| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |